We are live on ! Find out more
ARLZ

Aralez Pharmaceuticals Inc.
ARLZ

Delisted

ARLZ was delisted on the 20th of August, 2018.

Back to rankings

90 hedge funds and large institutions have $108M invested in Aralez Pharmaceuticals Inc. in 2016 Q1 according to their latest regulatory filings, with 90 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

27% less call options, than puts

Call options by funds: $1.22M | Put options by funds: $1.68M

Holders
90
Holders Change
+90
Holders Change %
–
% of All Funds
2.4%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.08%
New
90
Increased
–
Reduced
–
Closed
–
Calls
$1.22M
Puts
$1.68M
Net Calls
-$456K
Net Calls Change
-$456K

Top Buyers

Rank Fund Capital Flow
1
PCM
PAR Capital Management
Massachusetts
+$27.7M
2
BC
Broadfin Capital
New York
+$19.6M
3
JAM
JW Asset Management
Florida
+$9.47M
4
DM
Deerfield Management
New York
+$8.48M
5
JHIU
Janus Henderson Investors US
Colorado
+$8.16M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
ST
51
Spot Trading
Illinois
$186K +$270K +52,464 New
AIG
52
American International Group
New York
$185K +$269K +52,229 New
Norges Bank
53
Norges Bank
Norway
$172K +$249K +48,339 New
IP
54
Isthmus Partners
Wisconsin
$168K +$245K +47,442 New
Citigroup
55
Citigroup
New York
$162K +$235K +45,674 New
RhumbLine Advisers
56
RhumbLine Advisers
Massachusetts
$160K +$232K +44,973 New
AQR Capital Management
57
AQR Capital Management
Connecticut
$157K +$228K +44,200 New
Bank of Montreal
58
Bank of Montreal
Ontario, Canada
$142K +$206K +39,981 New
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
$132K +$191K +37,100 New
State Board of Administration of Florida Retirement System
60
State Board of Administration of Florida Retirement System
Florida
$117K +$170K +32,897 New
Group One Trading
61
Group One Trading
Illinois
$117K +$170K +32,963 New
Morgan Stanley
62
Morgan Stanley
New York
$116K +$169K +32,834 New
PAM
63
Panagora Asset Management
Massachusetts
$112K +$162K +31,453 New
Goldman Sachs
64
Goldman Sachs
New York
$109K +$159K +30,841 New
FMA
65
FNY Managed Accounts
New York
$107K +$155K +30,000 New
KJHP
66
K.J. Harrison & Partners
Ontario, Canada
$71K +$103K +20,000 New
Tudor Investment Corp
67
Tudor Investment Corp
Connecticut
$69K +$101K +19,500 New
Manulife (Manufacturers Life Insurance)
68
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$69K +$102K +19,807 New
Janney Montgomery Scott
69
Janney Montgomery Scott
Pennsylvania
$63K +$91.5K +17,750 New
SRC
70
Shufro Rose & Co
New York
$59K +$85K +16,487 New
BA
71
BlackRock Advisors
Delaware
$59K +$85.1K +16,500 New
AA
72
Ancora Advisors
Ohio
$59K +$85.7K +16,623 New
Creative Planning
73
Creative Planning
Kansas
$55K +$79.5K +15,425 New
Citadel Advisors
74
Citadel Advisors
Florida
$49K +$71.8K +13,933 New
VOYA Investment Management
75
VOYA Investment Management
Georgia
$48K +$69.4K +13,462 New
1 2
3
4

ARLZ Hedge Fund Activity: Q1 2016 in Review

90 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Aralez Pharmaceuticals Inc. (ARLZ) for Q1 2016, worth a combined $108M.

Buyers outnumbered sellers: 90 funds opened new ARLZ positions and 0 closed out — a net gain of 90 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was PAR Capital Management, opening a new position worth an estimated $27.7M.

  • 90 institutional investors held Aralez Pharmaceuticals Inc. (ARLZ) as of Q1 2016, up from 0 in Q4 2015.
  • Funds reported $108M of Aralez Pharmaceuticals Inc. stock for Q1 2016.
  • 90 funds opened new Aralez Pharmaceuticals Inc. positions in Q1 2016 and 0 closed out, a net change of +90 holders.
  • The largest Aralez Pharmaceuticals Inc. buyer in Q1 2016 was PAR Capital Management, an estimated $27.7M added.

Based on aggregated 13F filings for Q1 2016.